Azithromycin is an antibiotic drug. It can help treat a range of bacterial infections that affect the lungs, sinuses, skin, and other parts of the body. Learn about its uses, risks, side effects, and ...

Antibiotics for pneumonia include Zithromax (azithromycin), Biaxin (clarithromycin), and Erythrocin (erythromycin). Azithromycin is often the first-line treatment since it is effective against many ...

NEW YORK (Reuters Health) - A single-dose of the antibiotic azithromycin, sold in the U.S. under the trade name Zithromax, is recommended as the first therapy to use against traveler's diarrhea, ...

At IDWeek, 2025, held on 19–22 October, Dr Sarah McLeod from Innoviva Specialty Therapeutics presented subgroup analyses from a global Phase III noninferiority randomised controlled trial which ...

SingleCare inhibitions are now interdisciplinary at Tops Markets. If you have ever refined from a bacterial zithromax 500mg antibiotic relapse or a variety of other allergies of bacterial infections, ...

Macrolides are an important class of antibiotics that includes drugs such as azithromycin and erythromycin, which are widely used to treat a range of infections, including pneumonia and skin ...

Efforts to reduce child mortality in Africa via mass treatment with the antibiotic azithromycin (AZM) may lead to increased drug resistance in bacteria that frequently cause pneumonia and meningitis, ...

CHICAGO (AP) — An antibiotic widely used for bronchitis and other common infections seems to increase chances for sudden deadly heart problems, a rare but surprising risk found in a 14-year study.

Zithromax is a macrolide antibiotic to treat infections of upper and low respiratory tract, especially ear infections, pneumonia. As a Macrolide antibiotic Zithromax inhibits bacterial protein ...

Azithromycin appears to significantly increase patients’risk for sudden cardiac death compared with patients taking no antibiotics,results of an analysis reveal. The hazard ratio for cardiovascular ...

Community-wide distribution of azithromycin to both infants and children in Niger was effective in preventing deaths, but communities where only infants received the drug had no decrease in mortality, ...

Azithromycin for premature newborns requiring breathing support failed to improve rates of survival without moderate or severe bronchopulmonary dysplasia at 36 weeks' postmenstrual age, though it ...